High adherence to hymenoptera venom subcutaneous immunotherapy: a real life Italian experience

被引:0
|
作者
Kamberi, E. [1 ,2 ]
Brianzoni, M. F. [1 ]
Garritani, M. S. [1 ]
Antonicelli, L. [1 ]
Bonifazi, F. [1 ]
Bilo, M. B. [1 ]
机构
[1] Azienda Osped Univ Osped Riuniti Ancona, Dept Internal Med, Allergy Unit, Ancona, Italy
[2] Univ Politecn Marche, Scuola Specializzaz Allergol & Immunol Clin, Ancona, Italy
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
1089
引用
收藏
页码:400 / 401
页数:2
相关论文
共 50 条
  • [31] Factors associated with venom immunotherapy side-effects, re-sting reactions, and adherence in real-life
    Parke, Louise
    Kjaer, Henrik Fomsgaard
    Halken, Susanne
    Bindslev-Jensen, Carsten
    Mortz, Charlotte G.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (05): : 359 - 361
  • [32] The impact of the COVID-19 pandemic in Hymenoptera venom immunotherapy: a single center experience
    Abreu, Daniela brandao
    Braganca, Mariana
    Placido, JOse LUis
    Coimbra, Alice
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 55 (06) : 316 - 318
  • [33] Systematic review of real-world persistence and adherence in subcutaneous allergen immunotherapy
    Park, Michelle J.
    Kapoor, Shrey
    Yi, Julie
    Hura, Nanki
    Lin, Sandra Y.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2023, 13 (03) : 255 - 264
  • [34] Subcutaneous Immunotherapy With High-Dose Cat and Dog Extracts: A Real-life Study
    Uriarte, S. A.
    Sastre, J.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (03) : 169 - 174
  • [35] Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy
    Eitel, Tamara
    Zeiner, Kim Nikola
    Assmus, Katharina
    Ackermann, Hanns
    Zoeller, Nadja
    Meissner, Markus
    Kaufmann, Roland
    Kippenberger, Stefan
    Valesky, Eva Maria
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (05):
  • [36] The frequency of venom re-stings in field and protectiveness of venom immunotherapy: real life results
    Dalgic, Tunakan C.
    Gunsen, Dusunur F.
    Bulut, G.
    Ardeniz, F. O.
    Gulbahar, O.
    Gokmen, Mete E. N.
    Kokuludag, A.
    Sin, A. Z.
    ALLERGY, 2017, 72 : 681 - 681
  • [37] Italian real-life experience of omalizumab
    Cazzola, M.
    Camiciottoli, G.
    Bonavia, M.
    Gulotta, C.
    Ravazzi, A.
    Alessandrini, A.
    Caiaffa, M. F.
    Berra, A.
    Schino, P.
    Di Napoli, P. L.
    Maselli, R.
    Pelaia, G.
    Bucchioni, E.
    Paggiaro, P. L.
    Macchia, L.
    RESPIRATORY MEDICINE, 2010, 104 (10) : 1410 - 1416
  • [38] AN EXTENDED EXPERIENCE INDICATING THAT RAPID VENOM IMMUNOTHERAPY (RVIT) IS SAFE FOR TREATMENT OF HYMENOPTERA (HYM) ANAPHYLAXIS
    BERNSTEIN, JA
    KAGEN, SL
    BERNSTEIN, DI
    BERNSTEIN, IL
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 281 - 281
  • [39] Real-life experience with hazelnut oral immunotherapy
    Sabouraud, Marie
    Bierme, Priscille
    Andre-Gomez, Sylvie-Anne
    Villard-Truc, Florence
    Payot, Francois
    Correard, Anne-Karine
    Garnier, Lorna
    Braun, Camille
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (04) : 432 - 438
  • [40] Rush Hymenoptera venom immunotherapy:: A safe and practical protocol for high-risk patients
    Sturm, G
    Kränke, B
    Rudolph, C
    Aberer, W
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (06) : 928 - 933